Braun MM - Search Results

1

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. Keane J, et al. Among authors: braun mm. N Engl J Med. 2001 Oct 11;345(15):1098-104. doi: 10.1056/NEJMoa011110. N Engl J Med. 2001. PMID: 11596589 Free article.

2

Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor.

Mohan AK, Coté TR, Block JA, Manadan AM, Siegel JN, Braun MM. Mohan AK, et al. Among authors: braun mm. Clin Infect Dis. 2004 Aug 1;39(3):295-9. doi: 10.1086/421494. Epub 2004 Jul 16. Clin Infect Dis. 2004. PMID: 15306993

3

Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.

Lee JH, Slifman NR, Gershon SK, Edwards ET, Schwieterman WD, Siegel JN, Wise RP, Brown SL, Udall JN Jr, Braun MM. Lee JH, et al. Among authors: braun mm. Arthritis Rheum. 2002 Oct;46(10):2565-70. doi: 10.1002/art.10583. Arthritis Rheum. 2002. PMID: 12384912 Free article.

4

Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents.

Slifman NR, Gershon SK, Lee JH, Edwards ET, Braun MM. Slifman NR, et al. Among authors: braun mm. Arthritis Rheum. 2003 Feb;48(2):319-24. doi: 10.1002/art.10758. Arthritis Rheum. 2003. PMID: 12571839 Free article.

5

Epoetin and pure red-cell aplasia.

Braun MM, Wise RP, Wood JJ. Braun MM, et al. N Engl J Med. 2005 Feb 3;352(5):511-2; author reply 511-2. doi: 10.1056/NEJM200502033520518. N Engl J Med. 2005. PMID: 15689594 No abstract available.

6

Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents.

Mohan N, Edwards ET, Cupps TR, Slifman N, Lee JH, Siegel JN, Braun MM. Mohan N, et al. Among authors: braun mm. J Rheumatol. 2004 Oct;31(10):1955-8. J Rheumatol. 2004. PMID: 15468359

7

Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration.

Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Brown SL, et al. Among authors: braun mm. Arthritis Rheum. 2002 Dec;46(12):3151-8. doi: 10.1002/art.10679. Arthritis Rheum. 2002. PMID: 12483718 Free article.

8

Pure red-cell aplasia and recombinant erythropoietin.

Gershon SK, Luksenburg H, Coté TR, Braun MM. Gershon SK, et al. Among authors: braun mm. N Engl J Med. 2002 May 16;346(20):1584-6; author reply 1584-6. doi: 10.1056/NEJM200205163462015. N Engl J Med. 2002. PMID: 12015400 No abstract available.

9

Drug-induced systemic lupus erythematosus and TNF-alpha blockers.

Mohan AK, Edwards ET, Coté TR, Siegel JN, Braun MM. Mohan AK, et al. Among authors: braun mm. Lancet. 2002 Aug 24;360(9333):646. doi: 10.1016/S0140-6736(02)09800-8. Lancet. 2002. PMID: 12241965 No abstract available.

10

Infectious complications of biologic treatments of rheumatoid arthritis.

Mohan AK, Coté TR, Siegel JN, Braun MM. Mohan AK, et al. Among authors: braun mm. Curr Opin Rheumatol. 2003 May;15(3):179-84. doi: 10.1097/00002281-200305000-00002. Curr Opin Rheumatol. 2003. PMID: 12707568 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page